523.80MMarket Cap-45937P/E (TTM)
7.540High7.150Low214.89KVolume7.150Open7.440Pre Close1.59MTurnover0.44%Turnover RatioLossP/E (Static)71.27MShares8.70052wk High2.69P/B362.86MFloat Cap4.00052wk Low--Dividend TTM49.37MShs Float15.930Historical High--Div YieldTTM5.24%Amplitude2.305Historical Low7.405Avg Price1Lot Size
Cognyte Software Stock Forum
Cognyte Secures $10 Million Expansion with National Security Agency in EMEA
Cognyte Software (NASDAQ: CGNT) announced a $10 million follow-on order from a national security agency in the EMEA region. This long-term client will utilize Cognyte's advanced investigative analytics to derive more insights from increasing data volumes, combatting threats like terrorism, drug trafficking, and weapons smuggling. The order highlights the customer's satisfaction with Cognyt...
NEWS
Cognyte to Participate in the TD Cowen 52nd Annual Technology, Media & Telecom Conference
Cognyte Software (NASDAQ: CGNT) announced that its CEO, Elad Sharon, and CFO, David Abadi, will participate in an in-person fireside chat at the TD Cowen 52nd Annual Technology, Media & Telecom Conference.
The event will occur on Wednesday, May 29, 2024, at 10:15am ET. An online, real-time webcast and replay of the discussion will be available on Cognyte's investor relations...
$Target(TGT.US)$ +1.14% (Target announced it would increase its dividend by 1.9%, or 2 cents, to $1.10 per share.)
$Aldeyra Therapeutics(ALDX.US)$ +7.89% (Aldeyra announced it say statistical significance in the primary and all secondary endpoints for a drug that could be used for a type of eye inflammation.)
$Domino's Pizza(DPZ.US)$ +2.31% (The pizza chain rose 2.3% following an upgrade to buy from hold by Stifel. The firm ...
In company news, Cognyte Software $Cognyte Software(CGNT.US)$ rose almost 14% after the investigative analytics software firm Wednesday reported a non-GAAP loss of $0.04 per share in Q2, reversing a $0.17 per share adjusted p...
In reaction to earnings/guidance:
• $Thor Industries(THO.US)$ +2.5%
Other news:
• $Acumen Pharmaceuticals(ABOS.US)$+76.8% (in response with BIIB)
• $Biogen(BIIB.US)$ +45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint)
• $Nano X Imaging(NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multisource 3D digital tomosynthesis system)
• $Ocugen(OCGN.US)$ +9.3% (en...
• $Cadence Design Systems(CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $Federated Hermes(FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $Goldman Sachs(GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $McDonald's(MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $Oracle(ORCL.US)$ : Exane Upg...
No comment yet